Bioceltix is a biotechnology company that develops modern medicinal products for companion animals, with particular emphasis on dogs and horses. The company develops a proprietary technology for the production of biological drugs based on mesenchymal stem cells. The breakthrough of the Bioceltix approach lies in the use of a method that allows the administration of stem cells from a small number of healthy donors to a large number of patients, i.e. in an allogeneic model.
